Top Markets
#1 Islamic Coin Islamic Coin +152.28%
#2 Bitway Bitway +56.97%
#3 Starpower Starpower +37.21%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +28.40%
#5 aelf aelf +26.23%
#6 SkyAI SkyAI +19.20%
#7 Pons Pons +15.91%
#8 Decred Decred +14.29%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.08%
#10 DAPPOS DAPPOS +13.91%
Coin of the day
Islamic Coin Islamic Coin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
GenSight Biologics S.A. GenSight Biologics S.A.

GenSight Biologics S.A.

SIGHT
Classement en actions #29676
GenSight Biologics S.A. is a clinical-stage biotechnology firm focused on... GenSight Biologics S.A. is a clinical-stage biotechnology firm focused on identifying, advancing, and commercializing medical interventions for severe mitochondrial and neurodegenerative conditions affecting both the eyes and the central nervous system. Their therapeutic development leverages cutting-edge gene therapy platforms, specifically those involving mitochondrial targeting sequences and optogenetics. The company's leading drug candidate, LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, is currently undergoing Phase III clinical evaluation for treating Leber hereditary optic neuropathy (LHON) caused by a specific ND4 gene mutation. Another significant program, GS030, is engaged in Phase I/II clinical trials for retinitis pigmentosa and is also in the preclinical phase for dry age-related macular degeneration. Furthermore, GenSight Biologics is developing additional preclinical-stage programs aimed at various ophthalmic and neurodegenerative disorders. The company was founded in 2012 and maintains its headquarters in Paris, France.
Prix de l'action
$0.12098783
Capitalisation boursière
$19.72M
Changement (1 jour)
-2.49%
Changement (1 an)
-39.97%
Pays
FR
Échange GenSight Biologics S.A. (SIGHT)

Catégorie

Healthcare
Le prix SIGHT avec la capitalisation boursière de B
GenSight Biologics S.A. GenSight Biologics S.A.
SIGHT
$0.12098783
Capitalisation boursière de GenSight Biologics S.A.(SIGHT)
Capitalisation boursière: $19.72M
En August 2026, GenSight Biologics S.A. a une capitalisation boursière de $19.72M. Cela fait de GenSight Biologics S.A. la 29676th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de GenSight Biologics S.A. du 2016 au 2026
SIGHT par rapport au top 5 des plus populaires stocks
Prix pour SIGHT L’actif B La capitalisation boursière de B Résultats
GenSight Biologics S.A. GenSight Biologics S.A.
$32,555.70 $19.72M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.307T +26,908,142.59%
GenSight Biologics S.A. GenSight Biologics S.A.
$27,918.59 $19.72M
Apple Inc. Apple Inc.
AAPL
$4.551T +23,075,437.31%
GenSight Biologics S.A. GenSight Biologics S.A.
$25,486.88 $19.72M
Alphabet Inc. Alphabet Inc.
GOOG
$4.154T +21,065,559.84%
GenSight Biologics S.A. GenSight Biologics S.A.
$22,015.62 $19.72M
Microsoft Corporation Microsoft Corporation
MSFT
$3.589T +18,196,455.21%
GenSight Biologics S.A. GenSight Biologics S.A.
$17,158.56 $19.72M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.797T +14,181,958.43%